Search
Haemonetics Corp
HAEAdd to Watchlist
108.035USD
-0.485-0.45%
Market hours 09/23, 14:34（ET）
4.91BMarket Cap
52.38P/E TTM
Haemonetics Corp (HAE) Stock Price Target & Forecast
Analyst Rating
Based on 11 analysts giving stock ratings to Haemonetics Corp in the past month.
Buy
5 Strong Buy
4 Buy
2 Hold
0 Sell
0 Strong Sell
Target Price
114.333USD+5.47%
HAE Analyst Recommendation Trends
In the current month, HAE has received 4 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. HAE average Analyst price target in the last month is 114.333.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
5
4
4
4
3
3
3
3
4
4
4
4
4
4
4
4
2
3
3
3
4
4
4
4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11
11
11
11
11
11
11
11
HAE Analyst Rating for Peer Comparison
Updated: Sep 22, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Dexcom Inc
DXCM
13
13
4
0
0
30
Stryker Corp
SYK
11
13
6
0
0
30
Medtronic PLC
MDT
9
10
11
0
0
30
Abbott Laboratories
ABT
11
12
6
0
0
29
Zimmer Biomet Holdings Inc
ZBH
2
6
21
0
0
29
Medline Ord Shs Class A
MDLN
10
12
6
0
0
28
Guardant Health Inc
GH
12
13
2
0
0
27
Insulet Corp
PODD
7
8
12
0
0
27
Tandem Diabetes Care Inc
TNDM
5
8
10
0
0
23
Repligen Corp
RGEN
5
14
3
0
0
22
Financial Forecasting
Based on analysts' estimates, HAE EPS is projected to reach 1.291 in FY2027Q2, following reported EPS of 0.728 in FY2027Q1. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q3
FY2026Q4
FY2027Q1
FY2027Q2
FY2027Q3
Forecast
1.25
1.27
1.08
1.29
1.36
Actual
0.96
-0.44
0.73
--
--
Surprise
-23.52%
-134.27%
-32.42%
--
--
FAQs
What is Haemonetics Corp's expected revenue for the next quarter?
Haemonetics Corp's expected revenue is 345.00M.
What is Haemonetics Corp's price target?
Analysts forecast that Haemonetics Corp's price target is USD 114.33, with the highest forecast at USD 125.00 and the lowest forecast at USD 95.00.
How have Haemonetics CorpHAE's recent earnings per share performed?
The market expectation was USD 0.73, while Haemonetics CorpHAE's earnings per share (EPS) for the previous quarter was USD -0.44. EPS for the next quarter is expected at USD 1.29.
What is the analyst rating for Haemonetics Corp?
Based on the ratings of Haemonetics Corp's stock from 11 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.